Clinical trials: Kidney Transplant; Complications
Kidney Diseases
Steroid Withdrawal in Pediatric Renal Transplant Recipients Under Cyclosporine (CyA) and Mycophenolate Mofetil (MMF)
The present study investigates the safety and efficacy of steroid withdrawal in pediatric renal transplant recipients with stable graft function under concomitant immunosuppression with cyclosporine and mycophenolate mofetil.
- Trial name
- NCT00309218
- Testing
- methylprednisolone
- Where
- Germany
- Volunteers
- 42 people
- Sponsor
- Klinik für Kinder- und Jugendmedizin
Liver Cirrhosis, Copeptin
Copeptin Serum Level in Liver Transplant Recipients
The study aim is to measure perioperative copeptin concentration in blood of liver transplant recipients and to assess whether there is a correlation between its level and hemodynamic derangement.
- Conditions
- Liver Cirrhosis, Copeptin, Liver Transplant
- Trial name
- NCT03587623
- Where
- Poland
- Volunteers
- 38 people
- Sponsor
- Medical University of Warsaw
Kidney Diseases
Graft-first Versus Fistula-first in Older Patients With End-stage Kidney Disease
Many older adults require hemodialysis for advanced chronic kidney disease, but it is not clear which permanent vascular access method (fistula or graft) is best with respect to access effectiveness and patient satisfaction.
- Trial name
- GEMSSTAR (NCT03545113)
- Testing
- Upper arm arteriovenous graft surgery, Upper arm arteriovenous fistula surgery
- Where
- United States
- Volunteers
- 44 people
- Sponsor
- Wake Forest University Health Sciences
End Stage Renal Disease
Evaluation of STARgraft-2 for Hemodialysis Access
This study is a single site, prospective, single arm evaluation of the safety and effectiveness of the Healionics STARgraft-2 hemodialysis access graft.
- Trial name
- NCT04783779
- Testing
- Implant of STARgraft-2 shunt in the upper arm and subsequent use for hemodialysis access
- Where
- Paraguay
- Volunteers
- 24 people
- Sponsor
- Healionics Corporation
Kidney Donation, Kidney Failure
Live Kidney Donor Study -Renal Function Study
Kidney transplantation from living donors has been shown to carry many benefits over deceased donor transplantation. Because of benefits such as shorter waiting times and improved outcome for transplant recipients, living kidney…
- Conditions
- Kidney Donation, Kidney Failure, Kidney Transplantation
- Trial name
- NCT01158742
- Testing
- Glomerular Filtration Rate with Iothalamate, Glomerular Filtration Rate with Iohexol
- Where
- 3 sites in United States
- Volunteers
- 402 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Acute Kidney Injury, Liver Transplant; Complications
Risk of Acute Kidney Injury in Living Liver Donor Surgery
Acute kidney injury (AKI) is one of the most common complication after restricted fluid therapy for major surgery. The aim of this study is to evaluate the incidence of AKI as defined by Kidney Disease Improving Global Outcomes…
- Conditions
- Acute Kidney Injury, Liver Transplant; Complications, Fluid and Electrolyte Imbalance
- Trial name
- NCT05255510
- Where
- Turkey (Türkiye)
- Volunteers
- 130 people
- Sponsor
- Ankara University
Pediatric Renal Transplantation Complication
Predictors of Outcome of Pediatric Renal Transplantation
Renal transplantation is a unique chance to a normal life for end-stage renal disease patients, because of the perfect morphological and functional replacement of the lost kidneys.
- Trial name
- NCT06708988
- Volunteers
- 20 people
- Sponsor
- Assiut University
Kidney Cancer, Leukemia
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
RATIONALE: Traumeel® S (a mouth rinse) may be effective in preventing or decreasing the severity of oral mucositis caused by chemotherapy in young patients who are undergoing stem cell transplantation.
- Conditions
- Kidney Cancer, Leukemia, Lymphoma, Neuroblastoma
- Trial name
- NCT00080873
- Testing
- Traumeel S
- Where
- 44 sites in United States, Australia and 2 more
- Volunteers
- 195 people
- Sponsor
- Children's Oncology Group
End Stage Renal Disease, Kidney Transplantation
Desensitization of Renal Transplant Candidates
Trial of the use of Myfortic to reduce anti-HLA alloantibody in patients waiting for renal transplantation.
- Trial name
- NCT00298883
- Testing
- Myfortic
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- University of Florida
Infection, Cancer
TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation
Long-term outcomes in kidney transplantation remain a significant challenge, as complications such as donor-specific antibodies (DSA), antibody-mediated rejection, infections, and cancer increasingly threaten graft and patient…
- Conditions
- Infection, Cancer, Rejection, Kidney Transplantation
- Trial name
- TAOIST (NCT06829719)
- Testing
- TTV DNAemia, EQ-5D-5L questionnaire, Biological tests
- Where
- 4 sites in France
- Volunteers
- 600 people
- Sponsor
- Hospices Civils de Lyon
Immunosuppression, Kidney Transplant Rejection
The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma
Tacrolimus (TAC) is characterized by a narrow therapeutic window, as well as high inter- and intra-individual variability in pharmacokinetics. Both under- and overexposure may lead to severe adverse effects.
- Conditions
- Immunosuppression, Kidney Transplant Rejection, Kidney Transplant; Complications, Liver Transplant Rejection
- Trial name
- FreeTAC (NCT04657562)
- Testing
- Tacrolimus, Unbound tacrolimus measurement, CYP3A4 and CYP3A5 genotyping
- Where
- Poland
- Volunteers
- 380 people
- Sponsor
- National Science Centre, Poland
Aortic Aneurysm, Abdominal, Renal Insufficiency
Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm
This randomized controlled trial aim to determine the impact on renal function after treatment for infrarenal abdominal aortic aneurysm (AAA) with stentgrafts either with active supra- or infrarenal fixation.
- Conditions
- Aortic Aneurysm, Abdominal, Renal Insufficiency, Stent-Graft Thrombosis
- Trial name
- RENOFIX (NCT04754659)
- Testing
- Stentgraft
- Where
- Sweden
- Volunteers
- 252 people, healthy volunteers welcome
- Sponsor
- Vastra Gotaland Region
Kidney Failure, Chronic, End Stage Renal Failure With Renal Transplant
Black Star - Magnetic Stent Removal in Transplant Patients
This is a pilot, single-centre, feasibility study to assess the feasibility issues and collect preliminary clinical data for the design of future randomized controlled trial to evaluate the feasibility and patient comfort of…
- Trial name
- NCT03143556
- Testing
- Magnetic stent
- Where
- Canada
- Volunteers
- 40 people
- Sponsor
- St. Joseph's Healthcare Hamilton
Chronic Kidney Disease
Development and Effects of a Structural Education Program in Adult Kidney Transplant Recipients
Kidney transplantation is the treatment of choice for patients with end-stage renal disease. The purpose of this randomized and controlled study is to evaluate the efficacy of a structured education program for adult kidney…
- Trial name
- NCT01630824
- Testing
- Structured education program
- Where
- Germany
- Volunteers
- 180 people
- Sponsor
- University of Jena
Kidney Transplant; Complications, Pancreas Disease
Study of OmniGraft in Simultaneous Pancreas Kidney Recipients
The purpose of this research is learn about how OmniGraf works in kidney pancreas transplant patients. Also, to analyze the performance characteristics of OmniGrafTM (TruGraf Gene Expression Profiling (GEP) and T Cell Receptor…
- Trial name
- NCT06463873
- Where
- 2 sites in United States
- Volunteers
- 40 people
- Sponsor
- University of Miami
Chronic Kidney Failure
Belatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft Dysfunction
Calcineurin inhibitors (CNI) remain the standard treatment in renal transplantation to prevent rejection. Currently the main limitation of kidney transplantation is the occurrence of chronic graft dysfunction due to the CNI…
- Trial name
- BELASBRIDGE (NCT05562869)
- Testing
- Belatacept 250 Milligram Intravenous Powder for Solution
- Where
- France
- Volunteers
- 30 people
- Sponsor
- Nantes University Hospital
Renal Failure, End Stage
The ONE Study M Reg Trial
To collect evidence of the safety of administering donor-derived regulatory macrophage (M reg) preparations to living-donor renal transplant recipients in the context of an international European Union funded consortium aimed at…
- Trial name
- ONEmreg12 (NCT02085629)
- Testing
- Donor M reg (Mreg_UKR)
- Where
- Germany
- Volunteers
- 8 people
- Sponsor
- University of Regensburg
Kidney Failure
Everolimus Monotherapy as Immunosuppression After Liver Transplant
Tacrolimus is the standard immunosuppressive drug used to prevent organ rejection post liver transplant. One side effect of Tacrolimus is nephrotoxicity. Everolimus does not have the nephrotoxicity side effects of Tacrolimus.
- Trial name
- NCT04063865
- Testing
- Tacrolimus, Everolimus
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- Indiana University
Vascular Access Complication, Apheresis Related Complication
Vascular Access Complications for Therapeutic Apheresis in Nephrology
The aim of this study is to describe vascular access complications which are used for therapeutic apheresis in Nephrology.
- Trial name
- VACTANE (NCT05894317)
- Where
- France
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Central Hospital, Nancy, France
Hypotension During Surgery, Kidney Transplant; Complications
Hypotension Prediction With HPI Algorithm During Decessed-donor Kidney Transplant (HPI2022)
HPI monitoring and the adoption of therapeutic interventions before hypotension occurs should be ensure a shorter time of intra-operative hypotension (MAP < 65 mmHg) during deceased-donor kidney transplant surgery.
- Trial name
- HPI2022 (NCT05394896)
- Testing
- ACUMEN (Edwards Lifesciences, Irvine, USA), Invasive Blood Pressure
- Where
- Italy
- Volunteers
- 46 people
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.